Lung

, Volume 185, Issue 5, pp 309–314 | Cite as

Low Level of IGF-1 in Obesity May Be Related to Obstructive Sleep Apnea Syndrome

  • Ahmet Ursavas
  • Mehmet Karadag
  • Yesim Ozarda Ilcol
  • Ilker Ercan
  • Basak Burgazlioglu
  • Funda Coskun
  • R. Oktay Gozu
Article

Abstract

The aim of this study was to compare serum insulin-like growth factor (IGF-1) levels in patients with obstructive sleep apnea syndrome (OSAS) with those of nonapneic controls and to determine the risk factors of low IGF-1 levels in patients with OSAS. The study included 39 newly diagnosed moderate-to-severe OSAS patients and 36 nonapneic controls. Overnight polysomnography (PSG) was performed in all patients. The circulating levels of IGF-1 in the OSAS group were significantly lower than those of the control group (p < 0.05). There was a significant negative correlation between IGF-1 and logarithmic transformation (Ln) of the apnea-hypopnea index (AHI), duration of apnea-hypopnea, arousal index, average desaturation, and oxygen desaturation index (ODI). The result of stepwise regression analyses showed that OSAS (p = 0.001) was a risk factor for a low IGF-1 level, independent of age, gender, and body mass index (BMI). Our findings demonstrated that there was a significant negative correlation between IGF-1 and Ln AHI and that OSAS reduced the circulating levels of IGF-1.

Keywords

Insulin-like growth factor Obesity Sleep apnea 

References

  1. 1.
    Hedner J, Grote L (1998) Cardiovascular consequences of obstructive sleep apnea. Eur Respir Mon 10:227–265Google Scholar
  2. 2.
    Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A (2001) Prevalence of sleep disordered breathing in women; effects of gender. Am J Respir Crit Care Med 163:608–613PubMedGoogle Scholar
  3. 3.
    Kyzer S, Charuzi I (1998) Obstructive sleep apnea in the obese. World J Surg 22:998–1001PubMedCrossRefGoogle Scholar
  4. 4.
    Tapanainen P, Knip M (1992) Evaluation of growth hormone secretion and treatment. Ann Med 24:237–247PubMedGoogle Scholar
  5. 5.
    Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB (1993) Serum levels of insulin like growth factor I (IGF-I) and IGF binding protein 3 reflects spontaneous growth hormone secretion. J Clin Endocrinol Metab 76:1610–1616PubMedCrossRefGoogle Scholar
  6. 6.
    Engström BE, Karlsson FA, Wide L (1999) Gender differences in diurnal growth hormone and epinephrine values in young adults during ambulation. Clin Chem 45:1235–1239PubMedGoogle Scholar
  7. 7.
    Minuto F, Barreca A, Del Monte P, Fortini P, Resentini M, Morabito F, Giordano G (1988) Spontaneous growth hormone and somatomedin-C/insulin like growth factor-I secretion in obese subjects during puberty. J Endocrinol Invest 11:489–495PubMedGoogle Scholar
  8. 8.
    Bernstein D, Jasper JR, Rosenfeld RG, Hintz RL (1992) Decreased serum insulin like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest 89:1128–1132PubMedCrossRefGoogle Scholar
  9. 9.
    Gronfier C, Luthringer R, Follenius M, Schaltenbrand N, Macher JP, Muzet A, Brandenberger G (1996) A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment delta waves. Sleep 19:817–824PubMedGoogle Scholar
  10. 10.
    Bayes-Genis A, Conover CA, Schwartz RS (2000) The insulin like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 86:125–130PubMedGoogle Scholar
  11. 11.
    Rechtschaffen A, Kales A (eds) (1973) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects, 3rd ed. Los Angeles: Brain Research Institute, pp 1–13Google Scholar
  12. 12.
    Xu Y, Li S, Huang X, Cong B (2002) Insulin like growth factor-I and cognitive function in patients with obstructive sleep apnea syndrome. Zhonghua Yi Xue Za Zhi 82:1388–1390PubMedGoogle Scholar
  13. 13.
    McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195PubMedCrossRefGoogle Scholar
  14. 14.
    Gianotti L, Pivetti S, Lanfranco F, Tassone F, Navone F, Vittori E, Rossetto R, Gauna C, Destefanis S, Grottoli S, De Giorgi R, Gai V, Ghigo E, Maccario M (2002) Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 87:5052–5057PubMedCrossRefGoogle Scholar
  15. 15.
    Caufriez A, Golstein J, Lebrun P, Herchuelz A, Furlanetto R, Copinschi G (1984) Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects. Clin Endocrinol (Oxford) 20:65–70Google Scholar
  16. 16.
    Veldhuis JD, Iranmanesh A (1996) Physiologic regulation of the human growth hormone (GH)-insulin like growth factor type I (IGF-I) axis: predominant impact of age, obesity gonadal function, and sleep. Sleep 19(10 Suppl):S221–S224PubMedGoogle Scholar
  17. 17.
    Maccario M, Ramunni J, Oleandri SE, Procopio M, Grottoli S, Rossetto R, Savio P, Aimaretti G, Camanni F, Ghigo E (1999) Relatioship between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Metab Disord 23:612–618CrossRefGoogle Scholar
  18. 18.
    Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, Tehard B, Clavel-Chapelon F, van Gils CH, van Noord PA, Peeters PH, Bueno-de-Mesquita HB, Nagel G, Linseisen J, Lahmann PH, Boeing H, Palli D, Sacerdote C, Panico S, Tumino R, Sieri S, Dorronsoro M, Quiros JR, Navarro CA, Barricarte A, Tormo MJ, Gonzalez CA, Overvad K, Paaske Johnsen S, Olsen A, Tjonneland A, Travis R, Allen N, Bingham S, Khaw KT, Stattin P, Trichopoulou A, Kalapothaki V, Psaltopoulou T, Casagrande C, Riboli E, Kaaks R (2006) Body mass index, waist circumference, and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 30:1623–1631CrossRefGoogle Scholar
  19. 19.
    Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM, Sleep Heart Health Study Research Group (2002) Prediction of sleep disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162:893–900PubMedCrossRefGoogle Scholar
  20. 20.
    Issa FG, Sullivan CE (1986) The immediate effects of nasal continuous airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 63:10–17PubMedCrossRefGoogle Scholar
  21. 21.
    Zhang Y-S, Du J-Z (2000) The response of growth hormone and prolactin of rats to hypoxia. Neurosci Lett 279:137–140PubMedCrossRefGoogle Scholar
  22. 22.
    Han RN, Han VK, Buch S, Freeman BA, Post M, Tanswell AK (1998) Insulin-like growth factor binding proteins in air and 85% oxygen-exposed adult rat lung. Am J Physiol 274:L647–L656PubMedGoogle Scholar
  23. 23.
    Polo O, Berthon-Jones M, Douglas NJ, Sullivan CE (1994) Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet 344:656–660PubMedCrossRefGoogle Scholar
  24. 24.
    Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE (1989) Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airway pressure therapy. J Clin Endocrinol Metab 68:352–358PubMedCrossRefGoogle Scholar
  25. 25.
    Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJ (1995) Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and acute effect of continuous positive airway pressure (CPAP) treatment. Sleep 18:172–179PubMedGoogle Scholar
  26. 26.
    Lindberg E, Berne C, Elmasry A, Hedner J, Janson C (2006) CPAP treatment of a population-based sample—what are the benefits and the treatment compliance? Sleep Med 7:553–560PubMedCrossRefGoogle Scholar
  27. 27.
    Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P (1996) Sleep-disordered breathing in men with coronary artery disease. Chest 109:659–663PubMedGoogle Scholar
  28. 28.
    Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P (1996) Sleep-disordered breathing in women: occurrence and association with coronary disease. Am J Med 101:251–256PubMedCrossRefGoogle Scholar
  29. 29.
    Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091PubMedCrossRefGoogle Scholar
  30. 30.
    Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777–1789PubMedCrossRefGoogle Scholar
  31. 31.
    Laughlin GA, Barrett Connor E, Crıquı MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-I binding protein-1 levels with all-cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 89:114–120PubMedCrossRefGoogle Scholar
  32. 32.
    Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54PubMedGoogle Scholar
  33. 33.
    Poykko SM, Ukkola O, Kauma H, Kellokoski E, Horkko S, Kesaniemi A (2005) The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 48:309–316PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ahmet Ursavas
    • 1
    • 4
  • Mehmet Karadag
    • 1
  • Yesim Ozarda Ilcol
    • 2
  • Ilker Ercan
    • 3
  • Basak Burgazlioglu
    • 1
  • Funda Coskun
    • 1
  • R. Oktay Gozu
    • 1
  1. 1.Department of Pulmonary MedicineSchool of Medicine, University of UludagBursaTurkey
  2. 2.Department of BiochemistrySchool of Medicine, University Of UludagBursaTurkey
  3. 3.Department of BiostatisticsSchool of Medicine, University Of UludagBursaTurkey
  4. 4.Uludağ Üniversitesi Tıp FakültesiBursaTurkey

Personalised recommendations